-
-
-
-
-
-
-
Abbott presents positive 12-month data on atrial fibrillation devices
-
-
-
-
-
-
-
PharmaResearch gets FDA clearance for cancer drug trial
-
-
-
-
-
-
-
Atossa maintains eligibility for priority review voucher after program renewal
-
-
-
-
-
-
-
Powermax Minerals reports elevated rare earth elements in BC project
-
-
-
-
-
-
-
Biodexa licenses Otsuka's molecular glue therapy for rare cancer
-
-
-
-
-
-
-
Kodiak Sciences to present final KSI-101 phase 1b study results
-
-
-
-
-
-
-
GT Biopharma receives FDA clearance for GTB-5550 cancer treatment trial
-
73,936 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.

